STABLE FORMULATION FOR PARENTERAL ADMINISTRATION OF TAPENTADOL

The invention relates to an aqueous pharmaceutical composition for parenteral administration comprising Tapentadol or a physiologically acceptable salt thereof, wherein the concentration of Tapentadolis within the range of from 0.10 to 8.00mg/mL, based on the weight of Tapentadol free base and based...

Full description

Saved in:
Bibliographic Details
Main Authors SCHILLER MARC, WULSTEN EVA CORNELIA, BERTRAM ULRIKE, STRAUB STEFANIE, VAN HEMELRIJCK CARLOS, REINHOLD ULRICH
Format Patent
LanguageChinese
English
Published 27.03.2018
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:The invention relates to an aqueous pharmaceutical composition for parenteral administration comprising Tapentadol or a physiologically acceptable salt thereof, wherein the concentration of Tapentadolis within the range of from 0.10 to 8.00mg/mL, based on the weight of Tapentadol free base and based on the total volume of the composition; and wherein the pH value of the composition is buffered and within the range of from 4.0 to 6.0. The invention also relates to a container comprising the pharmaceutical composition and a process for the preparation thereof. The invention also relates to a kit comprising the contained according to the invention in a packaging. The pharmaceutical composition according to the invention is particularly useful for treating pain, especially acute pain, preferably in pediatric patients. 本发明涉及用于肠胃外给药的含水药物组合物,其包含他喷他多或其生理上可接受的盐,其中他喷他多的浓度为0.10至8.00mg/ml,基于他喷他多游离碱的重量并基于所述组合物的总体积;并且其中所述组合物的pH值被缓冲并为4.0至6.0。本发明还涉及包含所述药物组合物的容器和用于制备其的方法。本发明还涉及在包装中包含根据本发明的内容物的试剂盒。根据本发明的药物组合物特别用于治疗优选儿科患者中的疼痛,尤
Bibliography:Application Number: CN201680019084